Economist Podcasts Granting immunity: America weighs vaccine approval
Dec 8, 2020
Natasha Loader, The Economist's health policy editor, unveils the intricacies of the Pfizer vaccine approval process amidst an urgent push for emergency use in America. Meanwhile, Sarah Burke, a foreign correspondent, delves into the rising trend of multigenerational living in the West, exploring its roots in combating loneliness and economic pressures. Together, they examine the differences in regulatory approaches between the US and UK, shedding light on how societal shifts are reshaping living arrangements and health policies during the pandemic.
AI Snips
Chapters
Transcript
Episode notes
First Vaccine Recipient
- 90-year-old Margaret Keenan received the first Pfizer vaccine dose outside clinical trials in Britain.
- America awaits emergency authorization for the same vaccine.
Vaccine Approval Process
- America will hold a vaccine summit at the White House with vaccine makers and distributors.
- The FDA will convene a meeting to review the Pfizer vaccine data.
Vaccine Distribution Plans
- America's Operation Warp Speed aims to distribute vaccines within 24 hours of FDA approval.
- They plan to vaccinate 20 million Americans in December, but this is considered unrealistic.